申请人:Eli Lilly and Company
公开号:US05563147A1
公开(公告)日:1996-10-08
This invention provides novel, optionally substituted tetrahydropyridoindoles which are useful serotonergic agents for the treatment of central nervous system disorders.
这项发明提供了新颖的、可选择取代的四氢吡啶吲哚,它们是治疗中枢神经系统疾病的有效的5-羟色胺药物。